Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-03-11

Clinical Trial Update: Safety and Efficacy Study for the Treatment of Non-Aggressive Basal Cell Carcinoma With Photodynamic Therapy [Phase 3]

View source ↗

Summary

Phase 3 trial update for photodynamic therapy in non-aggressive basal cell carcinoma completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Biofrontera

Snippet

Sponsor: Biofrontera Bioscience GmbH | Conditions: Basal Cell Carcinoma (BCC) | Phase 3 | Status: COMPLETED | Results posted: 2019-03-11